Happy New Year to you all from everyone at Cure Leukaemia! We are delighted to share news of the expanded Centre for Clinical Haematology’s impact since it reopened exactly a year ago today.
Building on its growing reputation as an international centre of excellence for the treatment of blood cancer, the expanded centre has already had a dramatic impact on the treatment of haematological malignancies regionally and nationally. The £3.4m expansion was possible thanks to funding from The Greater Birmingham & Solihull Local Enterprise Partnership and Cure Leukaemia.
In its first 12 months the new centre:
- Now houses two pioneering blood cancer trials acceleration networks which were flagged in HM Government’s recent Life Sciences Industrial Strategy as exemplars of best practice.
- Led the development of four new clinical trials of novel drug and transplant therapies in blood cancer.
- Provided access to more than £10m in free drugs for clinical trial patients.
- Attracted £6m investment from the global pharmaceutical sector.
- Created 25 new jobs in the Life Sciences sector.
- Increased the Queen Elizabeth Hospital’s ability to deliver routine care for blood cancer patients and permitted stem cell transplants to be delivered as an outpatient thereby creating vital new NHS capacity.
- Unified clinical facilities for blood cancer under one roof to enhance the patient experience and provided capacity to look at changing some inpatient care to an outpatient setting.